WP 3 – Regulatory & Ethical
The Swedish Medical Products Agency (MPA, Läkemedelsverket) supports academic and business-related innovation activities and projects in respect of precision cancer health with timely regulatory, scientific and innovation advice in relation to oncology clinical trials.
Key Activities & Deliverables:
Promote academic and business-related innovation activities by simplifying the availability of regulatory and scientific expertise.
Promote development, education and information on regulations based on knowledge building from international cooperation within the so-called "Regulatory science" area in regards of oncology precision health
Provide project specific innovation advice sessions.
Provide Consultations between MPA and the partners in the milieu with special focus on the testbed trials and co-development.